Skip to main content

Generics

  • PCMA: Mail-service pharmacies drive generic utilization

    WASHINGTON — An organization representing the nation's pharmacy benefit managers said that mail-service pharmacies are increasing the use of generic medications.

    The Pharmaceutical Care Management Association issued a statement on Tuesday claiming that mail-service pharmacies leverage generic opportunities for savings, adding that there is no marked difference in the generic dispensing rate between mail-service pharmacy and retail pharmacy.

  • Meijer disputes belief that nothing is free

    The Midwest is known for flat landscapes and fertile farm fields stretching to the horizon, but it also is home to one of the country’s oldest and most successful mass merchandise chains — one with a long history of strong emphasis on pharmacy programs.


    Where a growing number of chains have adopted generic discount programs, Meijer has taken to giving many drugs away for free. The list of medications that customers can obtain at no charge now includes metformin for Type 2 diabetes, prenatal vitamins and most antibiotics.


  • Pozen, AstraZeneca file suit against Dr. Reddy's over generic Vimovo

    CHAPEL HILL, N.C. — A generic drug maker is being sued for patent infringement for its version of a fixed-dose combination drug co-created by Pozen and AstraZeneca.

  • Giant Eagle takes HBW to new heights

    You can’t be all things to all people, but you can be all things to one person. That’s the opportunity Giant Eagle is grabbing with the number of ways the Pittsburgh food-and-pharmacy retailer interacts with patients. 


    “Our goal is to help those within our communities live healthier, longer lives,” Dan Donovan, Giant Eagle spokesman, told Drug Store News. “We look to do this in a number of ways … [through] initiatives, such as our health and beauty care business, in-store retail health clinics and our group of skilled dietitians.”


  • Mylan gets OK for generic Femara

    PITTSBURGH — Mylan has launched a generic treatment for breast cancer, the drug maker said Monday.

    Mylan announced the launch of letrozole tablets in the 2.5-mg strength, an adjuvant treatment for postmenopausal women with hormone receptor-positive early-stage breast cancer.

    The drug is the first generic version of Novartis’ Femara, which had sales of about $682 million in 2010, according to IMS Health.

  • H-E-B adding clinics, new Rx services

    “After all, we’re from around here, too.” That message, delivered to millions of Texas consumers via the pharmacy page on H-E-B’s heavily scanned website, lies at the heart of the San Antonio-based supermarket chain’s seemingly unshakeable grip on both customers and patients in the Lone Star State. The H.E. Butt Grocery Co. maintains high marks for customer loyalty, innovative patient care services, a quality shopping experience and plenty of healthy choices in its food aisles.


  • Winn-Dixie renews ‘fresh & local’ appeal

    
If sports columnists covered Winn-Dixie, their story line would read something like this: The Jacksonville, Fla.-based retailer has climbed back into the ring as a slimmed-down and much-improved fighter competing in a lighter weight class. 


  • Report: Lupin's generic Fortamet receives FDA nod

    NEW DELHI — The Food and Drug Administration has approved a diabetes drug made by Lupin Pharmaceuticals, according to published reports.

    The FDA approved Lupin’s metformin hydrochloride extended-release tablets, a generic version of Andrx Labs’ Fortamet.

    Fortamet had sales of $83 million in 2010, according to IMS Health.

X
This ad will auto-close in 10 seconds